Meyka Pro banner
Celcuity Inc.

Celcuity Inc. Fundamental Analysis (NASDAQ: CELC)

CELCNASDAQ
HealthcareBiotechnology
$93.53
$0.12(0.13%)
U.S. Market opens in 64h 7m

Celcuity Inc. Fundamental Analysis (NASDAQ: CELC)

Celcuity Inc. (NASDAQ: CELC) shows weak financial fundamentals with a PE ratio of -21.35, profit margin of 0.00%, and ROE of -3.51%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Cash Position15.19%
Current Ratio8.93

Areas of Concern

ROE-3.51%
Operating Margin0.00%
We analyze CELC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 264.2/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
264.2/100

We analyze CELC's fundamental strength across five key dimensions:

Efficiency Score

Weak

CELC struggles to generate sufficient returns from assets.

ROA > 10%
-27.35%

Valuation Score

Excellent

CELC trades at attractive valuation levels.

PE < 25
-21.35
PEG Ratio < 2
1.02

Growth Score

Weak

CELC faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-33.57%

Financial Health Score

Excellent

CELC maintains a strong and stable balance sheet.

Debt/Equity < 1
-59.02
Current Ratio > 1
8.93

Profitability Score

Weak

CELC struggles to sustain strong margins.

ROE > 15%
-350.78%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is CELC Expensive or Cheap?

P/E Ratio

CELC trades at -21.35 times earnings. This suggests potential undervaluation.

-21.35

PEG Ratio

When adjusting for growth, CELC's PEG of 1.02 indicates fair valuation.

1.02

Price to Book

The market values Celcuity Inc. at -392.78 times its book value. This may indicate undervaluation.

-392.78

EV/EBITDA

Enterprise value stands at -21.02 times EBITDA. This is generally considered low.

-21.02

How Well Does CELC Make Money?

Net Profit Margin

For every $100 in sales, Celcuity Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-3.51 in profit for every $100 of shareholder equity.

-3.51%

ROA

Celcuity Inc. generates $-27.35 in profit for every $100 in assets, demonstrating efficient asset deployment.

-27.35%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-3.51 in free cash annually.

$-3.51

FCF Yield

CELC converts -4.34% of its market value into free cash.

-4.34%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-21.35

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

-392.78

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-59.02

vs 25 benchmark

Current Ratio

Current assets to current liabilities

8.93

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-3.51

vs 25 benchmark

ROA

Return on assets percentage

-0.27

vs 25 benchmark

ROCE

Return on capital employed

-0.28

vs 25 benchmark

How CELC Stacks Against Its Sector Peers

MetricCELC ValueSector AveragePerformance
P/E Ratio-21.3531.19 Better (Cheaper)
ROE-350.78%447.00% Weak
Net Margin0.00%21592.00% Weak
Debt/Equity-59.020.54 Strong (Low Leverage)
Current Ratio8.935.66 Strong Liquidity
ROA-27.35%-52.00% (disorted) Weak

CELC outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Celcuity Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-265.16%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-319.17%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ